TREATMENT FOR GOUT
| A | Suppresses immunity | |
| B | Increased uric acid excretion | |
| C | Decreased uric acid synthesis | |
| D | None of the above |
| A | Suppresses immunity | |
| B | Increased uric acid excretion | |
| C | Decreased uric acid synthesis | |
| D | None of the above |
Suppresses immunity
| A | Does not decrease the renal excretion of pencillin | |
| B | Does decrease the renal excretion of pencillin | |
| C | Has no effect | |
| D | At high doses increases and at low doses decreases |
| A | Does not decrease the renal excretion of pencillin | |
| B | Does decrease the renal excretion of pencillin | |
| C | Has no effect | |
| D | At high doses increases and at low doses decreases |
Does decrease the renal excretion of pencillin
Probenecid does NOT decrease the renal excretion of the following drug:
| A |
Ketoprofen |
|
| B |
Methotrexate |
|
| C |
Rifampin |
|
| D |
Penicillin |
Probenecid does NOT decrease the renal excretion of the following drug:
| A |
Ketoprofen |
|
| B |
Methotrexate |
|
| C |
Rifampin |
|
| D |
Penicillin |
- Methotrexate
- Active metabolite of clofibrate
- Inactive glucuronide metabolites of NSAIDs such as naproxen, ketoprofen, and indomethacin
- Penicillin
- Cephalosporins
Febuxostat is indicated in the treatment of:
| A |
Hyperkalemia |
|
| B |
Hyperuricemia |
|
| C |
Hypernatremia |
|
| D |
Hypercalcemia |
Febuxostat is indicated in the treatment of:
| A |
Hyperkalemia |
|
| B |
Hyperuricemia |
|
| C |
Hypernatremia |
|
| D |
Hypercalcemia |
Febuxostat is a non purine inhibitor of xanthine oxidase which is required for oxidation of hypoxanthine and xanthine to uric acid. It is usually used in gout especially in patients who are intolerant to allopurinol.
Other drugs used in the treatment of hyperuricemia:
- Uricosuric drugs
- Probenecid
- Sulfinpyrazone
Uric acid synthesis inhibitor
- Allopurinol
Ref: The Rheumatology Handbook By Margaret Callan, page 422.
A 44 year old businessman presents to a physician because of a markedly inflamed and painful right great toe.He states that he just returned from a convention, and had noticed increasing pain in his right foot during his plane trip home. Physical examination is remarkable for swelling and erythema of the right great toe as well as small nodules on the patient’s external ear. Aspiration of the metatarsal-phalangeal joint of the affected toe demonstrates needle-shaped negatively birefringent crystals. Which of the following agents would provide the most immediate relief for this patient?
| A |
Allopurinol |
|
| B |
Aspirin |
|
| C |
Colchicine |
|
| D |
Probenecid |
A 44 year old businessman presents to a physician because of a markedly inflamed and painful right great toe.He states that he just returned from a convention, and had noticed increasing pain in his right foot during his plane trip home. Physical examination is remarkable for swelling and erythema of the right great toe as well as small nodules on the patient’s external ear. Aspiration of the metatarsal-phalangeal joint of the affected toe demonstrates needle-shaped negatively birefringent crystals. Which of the following agents would provide the most immediate relief for this patient?
| A |
Allopurinol |
|
| B |
Aspirin |
|
| C |
Colchicine |
|
| D |
Probenecid |
The uricosuric agent used for acute gout in a chronic renal failure patient is:
| A |
Probenecid |
|
| B |
Colchicine |
|
| C |
Benzbromarone |
|
| D |
Aspirin |
The uricosuric agent used for acute gout in a chronic renal failure patient is:
| A |
Probenecid |
|
| B |
Colchicine |
|
| C |
Benzbromarone |
|
| D |
Aspirin |
Ischemia/reperfusion (I/R) injury is considered to be a MAJOR mechanism for organ transplant failure. Allopurinol is used in organ preservation as:
| A |
Antioxidant |
|
| B |
Preservative |
|
| C |
Free radical scavenger |
|
| D |
Precursor for energy metabolism |
Ischemia/reperfusion (I/R) injury is considered to be a MAJOR mechanism for organ transplant failure. Allopurinol is used in organ preservation as:
| A |
Antioxidant |
|
| B |
Preservative |
|
| C |
Free radical scavenger |
|
| D |
Precursor for energy metabolism |
The most commonly used solution for organ storage and flushing is the University of Wisconsin solution that contains lactobionate, raffinose, adenosine (a precursor for ATP generation), magnesium sulfate (to retard calcium influx), glutathione (as an antioxidant), and allopurinol (to inhibit xanthine oxidase induced reactive oxygen species (ROS) formation).
Ref: Immunobiology of Organ Transplantation edited by David S. Wilkes, William J. Burlingham, 2004, Page 548, 560.
A person has severe pain and swelling in great toe, True statement is/are:
- Allopurinol used in acute control of gout
- Colchicine acts slowly
- Colchicine causes gastrointestinal disturbances
- High serum uric acid level may not be present
- Joint fluid aspiration is done for investigation
| A |
1,2,3 |
|
| B |
3,4,5 |
|
| C |
2,4,5 |
|
| D |
All are correct |
A person has severe pain and swelling in great toe, True statement is/are:
- Allopurinol used in acute control of gout
- Colchicine acts slowly
- Colchicine causes gastrointestinal disturbances
- High serum uric acid level may not be present
- Joint fluid aspiration is done for investigation
| A |
1,2,3 |
|
| B |
3,4,5 |
|
| C |
2,4,5 |
|
| D |
All are correct |
“serum uric acid levels can be normal or low at the time of acute attack”. This limits the value of serum uric acid determination for the diagnosis of gout.
Nevertheless, serum urate levels are almost always elevated at some time and are important to use to follow the course of hyperuricemic therapy”
All of the following are true about Lesch–Nyhan syndrome, EXCEPT:
| A |
Affects almost solely males |
|
| B |
Excessive synthesis of purines is a feature |
|
| C |
Characterized by gouty arthritis |
|
| D |
Febuxostat is routinely used for treatment |
All of the following are true about Lesch–Nyhan syndrome, EXCEPT:
| A |
Affects almost solely males |
|
| B |
Excessive synthesis of purines is a feature |
|
| C |
Characterized by gouty arthritis |
|
| D |
Febuxostat is routinely used for treatment |
Lesch–Nyhan syndrome is a genetic disease, affecting almost solely males, of excessive synthesis of purines because of defective recycling and, therefore, uric acid production from their breakdown.
Lesch–Nyhan syndrome is characterized by gouty arthritis but, in addition, affects the brain, resulting in mental retardation, loss of control of arm/leg/face movements, aggressive behavior, and self-mutilation by biting and scratching.
Successful treatment of this disorder is still being sought.
A 47-year-old male patient presents with painful arthritis in the right big toe and uric acid renal stones. He has been taking allopurinol for his condition. What biochemical defect would likely be found in this patient?
| A |
A defect in urea synthesis |
|
| B |
An abnormality of the purine degradation pathway |
|
| C |
An inability to synthesize non-essential amino acids |
|
| D |
Defective topoisomerases |
A 47-year-old male patient presents with painful arthritis in the right big toe and uric acid renal stones. He has been taking allopurinol for his condition. What biochemical defect would likely be found in this patient?
| A |
A defect in urea synthesis |
|
| B |
An abnormality of the purine degradation pathway |
|
| C |
An inability to synthesize non-essential amino acids |
|
| D |
Defective topoisomerases |
Prolonged allopurinol therapy in a patient with gout is not indicated for –
| A |
Acute gouty arthritis |
|
| B |
Tophi |
|
| C |
Urate nephropathy |
|
| D |
Evidence of bone/joint damage |
Prolonged allopurinol therapy in a patient with gout is not indicated for –
| A |
Acute gouty arthritis |
|
| B |
Tophi |
|
| C |
Urate nephropathy |
|
| D |
Evidence of bone/joint damage |
Ans. is ‘a’ i.e., Acute gouty arthritis
o “Allopurinol as well as uricosuries should not be started during acute attack of gout”. –
o Tophi, urate nephropathy and bone & joint damage are seen in chronic gout.
o Allopurinol is the drug of choice for chronic gout.
Allopurinol is used in the treatment of ‑
| A |
Gout |
|
| B |
Hypothyroidism |
|
| C |
Hypertension |
|
| D |
Hyperlipidemia |
Allopurinol is used in the treatment of ‑
| A |
Gout |
|
| B |
Hypothyroidism |
|
| C |
Hypertension |
|
| D |
Hyperlipidemia |
Ans. is ‘a’ i.e., Gout
Allopurinol is the DOC for chronic gout.
Best drug for chronic gout in patient with renal impairment is –
| A |
Naproxen |
|
| B |
Probenecid |
|
| C |
Allopurinol |
|
| D |
Sulfinpyrazone |
Best drug for chronic gout in patient with renal impairment is –
| A |
Naproxen |
|
| B |
Probenecid |
|
| C |
Allopurinol |
|
| D |
Sulfinpyrazone |
Ans. is ‘c’ i.e., Allopurinol
o NSAIDs like naproxen have no role in chronic gout.
o Uricosuric drugs like probenecid and sulfinpyrazone are ineffective in the presence of renal insufficiency.
o Allopurinol is drug of choice for most cases of chronic gout.
Most common adverse effect of colchicine –
| A |
Diarrhoea |
|
| B |
Peptic ulcer |
|
| C |
Dyspepsia |
|
| D |
Pulmonary fibrosis |
Most common adverse effect of colchicine –
| A |
Diarrhoea |
|
| B |
Peptic ulcer |
|
| C |
Dyspepsia |
|
| D |
Pulmonary fibrosis |
Ans. is ‘a’ i.e., diarrhoea
“Nausea, vomiting, diarrhea and abdominal pain are the most common untoward effects of colchicine”. – Goodman & Gilman
Allopurinol prevents conversion of –
| A |
Hypoxanthine to xanthine |
|
| B |
Xanthine to hypoxanthine |
|
| C |
Hypoxanthine to I.M.P |
|
| D |
All |
Allopurinol prevents conversion of –
| A |
Hypoxanthine to xanthine |
|
| B |
Xanthine to hypoxanthine |
|
| C |
Hypoxanthine to I.M.P |
|
| D |
All |
Ans. is ‘a’ i.e., Hypoxanthine to xanthine
A patient receiving allopurinol requires dose reduction of-
| A |
6 mercaptopurine |
|
| B |
Cyclophosphamide |
|
| C |
Azathioprine |
|
| D |
a and c |
A patient receiving allopurinol requires dose reduction of-
| A |
6 mercaptopurine |
|
| B |
Cyclophosphamide |
|
| C |
Azathioprine |
|
| D |
a and c |
Ans. is ‘a’ i.e., 6 mercaptopurine; ‘c’ i.e., Azathioprine
o Allopurinol inhibits the degradation of 6-mercaptopurine and azathioprine, their doses should be reduced.
Which is an uricosuric drug-
| A |
Allopurinol |
|
| B |
Probenecid |
|
| C |
Indomethacin |
|
| D |
Aspirin |
Which is an uricosuric drug-
| A |
Allopurinol |
|
| B |
Probenecid |
|
| C |
Indomethacin |
|
| D |
Aspirin |
Ans. is ‘b’ i.e., Probenecid
- Uricosuric drugs are probenacid, sulfinpyrazone and benzbromarone.
Acute Gouty arthritis is seen early in treatment following –
| A |
Probenecid |
|
| B |
Allopurinol |
|
| C |
Rasburicase |
|
| D |
All of the above |
Acute Gouty arthritis is seen early in treatment following –
| A |
Probenecid |
|
| B |
Allopurinol |
|
| C |
Rasburicase |
|
| D |
All of the above |
All of the above
- Rapid lowering of urate level in chronic gout, by any means, may precipitate an attack of acute gout, probably by causing the dissolution of tophi.
o It is therefore usual to give prophylactic suppressive treatment with indomethacine, colchicine or steroid cover during first 2 months of allopurinol or uricosurics.
o Amongs the given options, allopurinol, probenecid and Rasburicase are the drugs that lower serum urate level.
- So, all three can precipitate acute gout. However, among these three, allopurinol is used most commonly therefore is the best answer here.
Febuxostat is used for ?
| A |
Hyperkalemia |
|
| B |
Hyperuricemia |
|
| C |
Hypernatremia |
|
| D |
Hypercalcemia |
Febuxostat is used for ?
| A |
Hyperkalemia |
|
| B |
Hyperuricemia |
|
| C |
Hypernatremia |
|
| D |
Hypercalcemia |
Ans. is ‘b’ i.e., Hyperuricemia
Febuxostat is a urate lowering drug, an inhibitor of xanthine oxidase that is indicated for use in the treatment of hyperuricemia and chronic gout.
Allopurinol is used in organ preservation as:
| A |
Antioxidant |
|
| B |
Preservative |
|
| C |
Free radical scavenger |
|
| D |
Precursor for energy metabolism |
Allopurinol is used in organ preservation as:
| A |
Antioxidant |
|
| B |
Preservative |
|
| C |
Free radical scavenger |
|
| D |
Precursor for energy metabolism |
Ans is c i.e. Free radical scavenger
Organ preservation is the supply line for organ transplantation. Currently, the liver, pancreas, and kidney can be successfully preserved for up to two days by flushing the organs with the University of Wisconsin (UW) solution and storing them at hypothermia (0-5° C). The UW solution is effective because it uses a number of cell impermeant agents (lactobionic acid, raffinose, hydroxyethyl starch) that prevent the cells from swelling during cold ischemic storage. Additionally, the UW solution contains glutathione, allopurinol and adenosine, agents that may stimulate recovery of normal metabolism upon reperfusion by augmenting the antioxidant capacity of the organs (glutathione) or by stimulating high-energy phosphate generation (adenosine) upon reperfusion and allopurinol as free-radical scavenger.
- Glutathione as antioxidant
- Adenosine as precursor for energy metabolism
- Allopurinol as free-radical scavenger
All of the following Drugs are used in treatment of chronic gout, except:-
| A |
Allopurinol |
|
| B |
Benzbromarone |
|
| C |
Pegloticase |
|
| D |
Methotrexate |
All of the following Drugs are used in treatment of chronic gout, except:-
| A |
Allopurinol |
|
| B |
Benzbromarone |
|
| C |
Pegloticase |
|
| D |
Methotrexate |
Answer is D (Methotrexate):
To Lower Uric Acid Levels (Hypouricemic Therapy)
To decrease production of uric acid (Xanthine Oxidase Inhibitors)
- Allopurinol(Purine analogue)
- Febuxostat (Non-purine selective inhibitor of xanthine oxidase)
To increase the excretion of uric acid (Uricosurics)
- Probenecid
- Sulfinpyrazone
- Benzbromarone
To increase conversion of Uric acid to Allantoin which is far more soluble (Uricase)
- Pegloticase
All of the following statements about Acute Attack in gouty arthritis are true, except:-
| A |
Joint aspirate reveals negative birefringent crystals |
|
| B |
Allopurinol should be started immediately |
|
| C |
Colchicine is known to provide relief |
|
| D |
Serum uric acid levels may be normal |
All of the following statements about Acute Attack in gouty arthritis are true, except:-
| A |
Joint aspirate reveals negative birefringent crystals |
|
| B |
Allopurinol should be started immediately |
|
| C |
Colchicine is known to provide relief |
|
| D |
Serum uric acid levels may be normal |
Answer is B (Allopurinol should be started immediately):
Allopurinol should not be started immediately in acute attack of gout as it may precipitate acute symptoms.
The mainstay of treatment in acute gouty arthritis is the administration of anti inflammatory drugs such as NSAID, Cochicine and /or glucocorticoids.
Allopurinol should not be started immediately in Acute attack of Gout
Allopurinol should never be started in acute gout as it may actually precipitate an acute attack.
Anti inflammatory drugs such as NSAIDs are the drugs of choice in acute gout.
Joint aspirate typically reveals strongly negative birefringent needle shaped crystals
Definitive diagnosis of gout requires aspiration of the involved joint and demonstration of intracellular monosodium urate crystals in synovial fluid.
Under polarized light these are demonstrated as “strongly negative birefringent needle shaped crystals.”
Tophi are aggregates of monosodium urate monohydrate crystals that form in extra articular and articular structures and cause deformity and destruction of hard and soft tissue.
Serum uric acid levels may be normal in Acute Gout
Gout is caused whenever; synovial fluid is supersaturated with uric acid, irrespective of serum concentration of uric acid.
The serum levels of uric acid can be normal or even low at the time of an attack and hence its determination is not diagnostic for gout.
`Serum uric acid levels may be normal or low at the time of an acute attack, as inflammatory cytokines can be uricosuric and effective initiation of hypourecemic therapy can precipitate attacks.
This limits the value of serum uric acid determination for the diagnosis of gout ‘- Harrison’s 18th/2838
Allopurinol acts by inhibiting:
| A |
Uric acid carboxylase |
|
| B |
Hypoxanthine oxidase |
|
| C |
Uric acid synthase |
|
| D |
Xanthine oxidase |
Allopurinol acts by inhibiting:
| A |
Uric acid carboxylase |
|
| B |
Hypoxanthine oxidase |
|
| C |
Uric acid synthase |
|
| D |
Xanthine oxidase |
Mechanism of action of colchicine is ‑
| A |
Inhibits gouty inflammation |
|
| B |
Inhbits the release of chemotactic factors |
|
| C |
Inhibits granulocyte migration |
|
| D |
All the above |
Mechanism of action of colchicine is ‑
| A |
Inhibits gouty inflammation |
|
| B |
Inhbits the release of chemotactic factors |
|
| C |
Inhibits granulocyte migration |
|
| D |
All the above |
Ans. is ‘d’ i.e., All the above
Colchicine
- It is neither analgesic nor anti inflammatory.
- It specifically inhibits gouty inflammation.
- It is inhibits release of chemoattractant molecules.
- It inhibits granulocyte migration into the joint.
- It is antimitotic causes metaphase arrest by binding to microtubules.
- It increases gut motility.
Probenecid interacts with ‑
| A |
Streptomycin |
|
| B |
Ampicillin |
|
| C |
Vancomycin |
|
| D |
Erythromycin |
Probenecid interacts with ‑
| A |
Streptomycin |
|
| B |
Ampicillin |
|
| C |
Vancomycin |
|
| D |
Erythromycin |
Ans. is ‘b’ i.e., Ampicillin
Interactions of probenecid
- Probenecid inhibits urinary excretion of penicillins, cephalosporins, methotrexate, sulfonamides and indomethacin.
- It inhibits biliary excretion of rifampicin.
- Salicylates block uricosuric action of probenecid.
- Probenecid inhibits tubular secretion of nitrofurantoin.
- Pyrazinamide and ethambutol may interfere with uricosuric action of probenecid.
Note : Ampicillin is a penicillin.
Uricase used in the treatment of chronic gout is
| A |
Allopurinol |
|
| B |
Benzbromarone |
|
| C |
Pegloticase |
|
| D |
Methotrexate |
Uricase used in the treatment of chronic gout is
| A |
Allopurinol |
|
| B |
Benzbromarone |
|
| C |
Pegloticase |
|
| D |
Methotrexate |
Ans. is ‘c‘ i.e., Pegloticase
Pegloticase is a recombinant mammalian Uricase linked to polyethylene glycol (PEG) approved for the treatment
- of Hyperuricemia in patients with treatment refractory gout.
- Pegloticase facilitates the conversion of Uric acid into allantoin, which is far more soluble. Pegloticase is approved for intravenous administration and its use is associated with rapid and marked decline in serum uric acid levels.
Agents inhibiting IL-1 action are used for the treatment of refractory Gout
- Anakinra
- Canakinumab




